blinatumomab
Showing 51 - 59 of 59
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,
Recruiting
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- Blinatumomab
- +10 more
-
Anchorage, Alaska
- +152 more
Aug 11, 2022
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)
Recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Blinatumomab
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Feb 21, 2021
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome Trial in Worldwide (drug, biological, radiation)
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase Erwinia chrysanthemi
- +15 more
-
Birmingham, Alabama
- +219 more
Aug 24, 2022
ALL, Childhood, Minimal Residual Disease Trial in Worldwide (Blinatumomab)
Recruiting
- ALL, Childhood
- Minimal Residual Disease
- Blinatumomab
-
Vienna, Austria(AUT), Austria
- +14 more
Mar 4, 2021
Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Blinatumomab
- +18 more
-
Sydney, Australia
- +114 more
Nov 1, 2022
Leukemia, Acute Lymphoblastic Trial in Worldwide (Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab
Recruiting
- Leukemia, Acute Lymphoblastic
- Omitted Doxorubicin
- +5 more
-
Brussels, Belgium
- +100 more
Dec 12, 2022
B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)
Completed
- B-cell Acute Lymphoblastic Leukemia
- Blinatumomab
-
Graz, Austria
- +74 more
Jan 31, 2020
Acute Lymphoblastic Leukemia Trial in Italy (Dasatinib, Blinatumomab)
Unknown status
- Acute Lymphoblastic Leukemia
- Dasatinib
- Blinatumomab
-
Ascoli Piceno, Italy
- +33 more
Mar 21, 2018
Diffuse Large B-cell Lymphoma Trial in Germany (Blinatumomab)
Completed
- Diffuse Large B-cell Lymphoma
- Blinatumomab
-
Göttingen, Germany
- +5 more
Nov 9, 2016